Overview
Ashley Brzezinski advises clients on medical technology and life sciences intellectual property matters, particularly on strategic portfolio development and transactional due diligence. Ashley represents clients in areas such as medical technology, consumer devices, robotics, artificial intelligence, computer-assisted medical solutions and bioinformatics. Ashley also performs IP due diligence studies in transactions involving life science companies, provides invalidity and non-infringement opinions and represents clients in reexamination and post-grant proceedings.
Ashley received BS, MS and PhD degrees in Electrical Engineering and Computer Science, and completed a postdoctoral fellowship at Harvard Medical School following her PhD. Ashley’s research background includes optical tomography and inverse imaging problems (e.g., medical applications) and communication problems (e.g., orthogonal frequency division multiplexing (OFDM) and ultra-wide band (UWB)).
While in graduate school, Ashley served as a research intern at a major research lab, where she worked on various projects, such as construction of M-QAM signals utilizing Q-PSK Golay sequences for OFDM systems. Ashley’s research on time hopping sequence for narrowband interference suppression has been the subject of two US patents, namely US Patent No. 8,406,278 and US Patent No. 8,687,672.
After completing her PhD, Ashley was a postdoctoral fellow at the Center for Bioinformatics of the department of Radiology of Brigham and Women’s Hospital-Harvard Medical School. During her postdoctoral fellowship, Ashley worked on developing computational algorithms that aid diagnosis, therapy, prognosis, repair and prevention of neurodegenerative diseases and related disorders.
Ashley’s research has been published in several peer-reviewed publications, including IEEE Trans. on Communication, Radio Science, IEEE Trans. on Geoscience & Remote Sensing, NeuroImage, BMC Cell Biology and Computerized Medical Imaging and Graphics.
Ashley concentrated on Intellectual Property Law in law school. She won first place in the Boston Patent Law Association’s 2016 Annual Writing Competition for her article titled “Visual Artists Rights Act (VARA) and the Protection of Digital Embodiments of Artworks.”
Results
- Advised a digital therapeutics company in its acquisition of a UK virtual reality company focused on utilizing digital therapeutics for anxiety, pain management and maternal health
- Advised a Swedish global investment firm on its €2.8 billion acquisition of a global provider of mission critical biopharma transport services*
- Advised a large SPAC in its $1.1 billion SPAC formation and acquisition of a manufacturer of robotic surgical tools*
- Advised a South Korean private equity firm in its $100 million investment in a manufacturer of robotic surgical products*
- Advised a prominent impact fund in its acquisition of a manufacturer of next-generation solutions for continuous, noninvasive monitoring of in vitro cell models*
- Advised a biotechnology company in its acquisition of a biotechnology company that focuses on smart devices and imaging*
- Advised private equity investors in the investment of a Swedish manufacturer of sustainable wood packaging materials*
*Matter handled prior to joining McDermott
Recognitions
- The Best Lawyers in America: Ones to Watch, Intellectual Property, Boston, 2023 to 2024
- Super Lawyers, Massachusetts Rising Star, 2023
- First place, Boston Patent Law Association’s Annual Writing Competition, 2016
Community
- Massachusetts State Bar, member
Credentials
Education
Boston University School of Law, JD
Northeastern University, PhD, Electrical Engineering and Computer Science
Northeastern University, MS, Electrical Engineering and Computer Science
Fairleigh Dickinson University, BS, Electrical Engineering and Computer Science
Admissions
Massachusetts
Courts/Agencies
US Patent and Trademark Office
